(Q80799407)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700531%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Collagen matrix assembly is driven by the interaction of von Hippel-Lindau tumor suppressor protein with hydroxylated collagen IV alpha 2 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700531%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700531%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

G Kurban

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700531%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

N Ramlal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700531%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

V Hudon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700531%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Y Sado

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700531%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Y Ninomiya

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700531%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

A Pause

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700531%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

13 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700531%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700531%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700531%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

1004-1012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700531%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17700531%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210709

3 January 2020

exact match

0 references

cites work

The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210709

7 January 2021

Genetic analysis of pathways regulated by the von Hippel-Lindau tumor suppressor in Caenorhabditis elegans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210709

7 January 2021

Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210709

7 January 2021

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210709

7 January 2021

Interaction of hydroxylated collagen IV with the von hippel-lindau tumor suppressor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210709

7 January 2021

Metalloproteinases and their inhibitors in tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210709

7 January 2021

von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210709

7 January 2021

Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210709

7 January 2021

Molecular basis of the VHL hereditary cancer syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210709

7 January 2021

Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210709

7 January 2021

Characterization of a von Hippel Lindau pathway involved in extracellular matrix remodeling, cell invasion, and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210709

7 January 2021

Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210709

7 January 2021

The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210709

7 January 2021

Collagens: molecular biology, diseases, and potentials for therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210709

7 January 2021

Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210709

7 January 2021

Endoplasmic reticulum/cytosolic localization of von Hippel-Lindau gene products is mediated by a 64-amino acid region

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210709

7 January 2021

Targeting HIF-1 for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210709

7 January 2021

The NC1 domain of human collagen IV is necessary to initiate triple helix formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210709

7 January 2021

pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210709

7 January 2021